Participation in a specialty pharmacy improved control of secondary hyperparathyroidism in hemodialysis (HD) patients, researchers reported at ASN's Renal Week 2009.

Etelcalcetide is a calcimimetic agent that decreases parathyroid levels in patients with chronic kidney disease on dialysis who develop secondary hyperparathyroidism.

Hungry bone syndrome occurs in 1 of 5 patients after parathyroidectomy for secondary hyperparathyroidism of renal origin, a study found.

SECONDARY hyperparathyroidism associated with chronic renal disease may simulate primary hyper-parathyroidism with secondary renal impairment in virtually every particular. An exception is the brow ...

Secondary hyperparathyroidism and increased serum fibroblast growth factor 23 (FGF-23) levels in chronic kidney disease (CKD) are intimately related; secondary hyperparathyroidism has a crucial ...

SECONDARY parathyroid hyperplasia resulting from long standing renal insufficiency is a well described entity whose characteristics have been described by Castleman and Mallory1 and others.2 , 3 Mo ...

(Reuters) - The U.S. Food and Drug Administration has approved Amgen Inc's treatment for secondary hyperparathyroidism in adult patients with chronic kidney disease undergoing dialysis, the U.S ...

Tertiary hyperparathyroidism This type occurs when a person has long standing secondary hyperparathyroidism. This type of hyperparathyroidism typically occurs in people with kidney problems.

Using lower parathyroid hormone targets to manage secondary hyperparathyroidism may lower mortality and CVD in patients on hemodialysis, a study found. “Secondary hyperparathyroidism is a common ...

This review focuses on the role of drugs such as cinacalcet in the treatment of uremic secondary hyperparathyroidism. Another indication discussed is predialysis secondary hyperparathyroidism.

The U.S. Food and Drug Administration has approved OPKO Health Inc.’s Rayaldee (calcifediol) extended release capsules to treat secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 ...